Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.
AbbVie Inc. (ABBV) had Cost of Goods Sold of $4.29B for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
$17.40B |
|
$4.22B |
|
|
Cost of Goods Sold |
$4.29B |
$13.12B |
|
$11.14B |
|
$6.27B |
|
$38.00M |
|
$4.83B |
|
$4.83B |
|
$4.22B |
|
$4.22B |
|
$4.22B |
|
$4.22B |
|
$6.27B |
|
-- |
|
-- |
|
1.77B |
|
-- |
|
$2.37 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
$0.00M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|